Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy
Nano Letters · 05.03.2025 · 25 (9) · 3670-3680
DOI: 10.1021/acs.nanolett.5c00358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 24.02.2025. Verfasst von Yan-Tong Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Department of Cardiology, Zhongnan Hospital, Wuhan Universi…. Hauptthemen laut MEDLINE: Hydrogels, Doxorubicin, Immunotherapy, Membrane Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In this study, an acid-responsive hydrogel (ODCM@AZD) encapsulating doxorubicin (DOX), Mn2+, and AZD2281 is rationally engineered for synergistic chemo-immunotherapy. Notably, ODCM@AZD can be specifically degraded within the tumor microenvironment to release the loaded therapeutic agents. Specifically, the released DOX kills tumor cells to produce abundant cytoplasmic DNA, while the freed AZD2281 inhibits the DNA repair pathway of tumor cells to enhance the chemotherapeutic effect and promote the accumulation of damaged DNA, which is further aggravated by reactive oxygen species (ROS) generated from the Mn2+-mediated Fenton-like reaction. Not only that, Mn2+ simultaneously increases the sensitivity of cGAS to cytoplasmic DNA to stimulate the cGAS-STING pathway and synergizes with DOX-mediated immunogenic cell death (ICD) to initiate powerful antitumor immune responses. More importantly, the combination of ODCM@AZD with immune checkpoint blockade (ICB) significantly improves systemic tumoricidal immunity and potentiates therapeutic effects on distant and recurrent tumor models, providing a new idea for antitumor chemo-immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan 430072, P. R. China.
ORCID-Profile: Jun-Long Liang, Wei-Hai Chen, Xian-Zheng Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Lin, Y. T., Meng, R., Zhang, S. M., Zhou, H., Chen, H., Liang, J. L., Yao, W. Q., Chen, W. H., & Zhang, X. Z. (2025). Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy. Nano Letters, 25(9), 3670-3680. https://doi.org/10.1021/acs.nanolett.5c00358
Vancouver
Lin YT, Meng R, Zhang SM, Zhou H, Chen H, Liang JL, et al. Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy. Nano Letters. 2025;25(9):3670-3680. doi:10.1021/acs.nanolett.5c00358
BibTeX
@article{Lin2025,
author = {Lin, Yan-Tong and Meng, Ran and Zhang, Shi-Man and Zhou, Hao and Chen, Hong and Liang, Jun-Long and Yao, Wei-Qin and Chen, Wei-Hai and Zhang, Xian-Zheng},
title = {Acid-Responsive Biocompatible Hydrogel Modulating Tumor DNA Self-Repair Collaborated with Chemotherapy for Boosting STING Pathway-Associated Immunotherapy},
journal = {Nano Letters},
year = {2025},
volume = {25},
number = {9},
pages = {3670--3680},
doi = {10.1021/acs.nanolett.5c00358}
}
EUVIMED